60 related articles for article (PubMed ID: 23790165)
21. Proliferative Potential, and Inflammatory Tumor Microenvironment in Meningioma Correlate with Neurological Function at Presentation and Anatomical Location-From Convexity to Skull Base and Spine.
Wach J; Lampmann T; Güresir Á; Vatter H; Herrlinger U; Becker A; Cases-Cunillera S; Hölzel M; Toma M; Güresir E
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205781
[TBL] [Abstract][Full Text] [Related]
22. Combining FORGE Score and Histopathological Diagnostic Criteria of Atypical Meningioma Enables Risk Stratification of Tumor Progression.
Wach J; Lampmann T; Güresir Á; Vatter H; Becker AJ; Hölzel M; Toma M; Güresir E
Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829359
[TBL] [Abstract][Full Text] [Related]
23. FORGE: A Novel Scoring System to Predict the MIB-1 Labeling Index in Intracranial Meningiomas.
Wach J; Lampmann T; Güresir Á; Schuss P; Vatter H; Herrlinger U; Becker A; Hölzel M; Toma M; Güresir E
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298854
[TBL] [Abstract][Full Text] [Related]
24. Case Report: Long-Term Chemotherapy With Hydroxyurea and Prednisolone in a Cat With a Meningioma: Correlation of FDG Uptake and Tumor Grade Assessed by Histopathology and Expression of Ki-67 and p53.
Yun T; Koo Y; Kim H; Lee W; Kim S; Jung DI; Yang MP; Kang BT
Front Vet Sci; 2021; 8():576839. PubMed ID: 33575281
[TBL] [Abstract][Full Text] [Related]
25. Comparative Analysis of the MRI Characteristics of Meningiomas According to the 2016 WHO Pathological Classification.
Yu J; Chen FF; Zhang HW; Zhang H; Luo SP; Huang GD; Lin F; Lei Y; Luo L
Technol Cancer Res Treat; 2020; 19():1533033820983287. PubMed ID: 33356976
[TBL] [Abstract][Full Text] [Related]
26. The Preferred Locations of Meningioma According to Different Biological Characteristics Based on Voxel-Wise Analysis.
Sun C; Dou Z; Wu J; Jiang B; Iranmanesh Y; Yu X; Li J; Zhou H; Zhong C; Peng Y; Zhuang J; Yu Q; Wu X; Yan F; Xie Q; Chen G
Front Oncol; 2020; 10():1412. PubMed ID: 32974148
[No Abstract] [Full Text] [Related]
27. Recurrence/Regrowth in Grade I Meningioma: How to Predict?
de Carvalho GTC; da Silva-Martins WC; de Magalhães KCSF; Nunes CB; Soares AN; Tafuri LSA; Simões RT
Front Oncol; 2020; 10():1144. PubMed ID: 32903787
[TBL] [Abstract][Full Text] [Related]
28. The prognostic role of Ki-67/MIB-1 in meningioma: A systematic review with meta-analysis.
Liu N; Song SY; Jiang JB; Wang TJ; Yan CX
Medicine (Baltimore); 2020 Feb; 99(9):e18644. PubMed ID: 32118704
[TBL] [Abstract][Full Text] [Related]
29. Nucleotide variations of
Bukovac A; Kafka A; Hrašćan R; Vladušić T; Pećina-Šlaus N
Mol Clin Oncol; 2019 Dec; 11(6):563-572. PubMed ID: 31692929
[TBL] [Abstract][Full Text] [Related]
30. Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature.
Bender L; Lhermitte B; Carinato H; Baloglu S; Helali M; Cebula H; Antoni D; Noel G
World J Surg Oncol; 2019 Apr; 17(1):70. PubMed ID: 30992070
[TBL] [Abstract][Full Text] [Related]
31. In situ characterization of stem cells-like biomarkers in meningiomas.
Alamir H; Alomari M; Salwati AAA; Saka M; Bangash M; Baeesa S; Alghamdi F; Carracedo A; Schulten HJ; Chaudhary A; Abuzenadah A; Hussein D
Cancer Cell Int; 2018; 18():77. PubMed ID: 29849507
[TBL] [Abstract][Full Text] [Related]
32. Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression.
Pećina-Šlaus N; Kafka A; Vladušić T; Tomas D; Logara M; Skoko J; Hrašćan R
Int J Exp Pathol; 2016 Apr; 97(2):159-69. PubMed ID: 27292269
[TBL] [Abstract][Full Text] [Related]
33. Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer.
Halabi NM; Martinez A; Al-Farsi H; Mery E; Puydenus L; Pujol P; Khalak HG; McLurcan C; Ferron G; Querleu D; Al-Azwani I; Al-Dous E; Mohamoud YA; Malek JA; Rafii A
PLoS Genet; 2016 Jan; 12(1):e1005755. PubMed ID: 26735499
[TBL] [Abstract][Full Text] [Related]
34. Are Osteopontin and Ki67 Expressions Different in Various Histologic Grades of Meningioma? An Iranian Experience.
Hashemi F; Babaheidarian P; Dabiran S
Iran J Pathol; 2015; 10(4):253-7. PubMed ID: 26351494
[TBL] [Abstract][Full Text] [Related]
35. Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence.
Trott G; Pereira-Lima JF; Leães CG; Ferreira NP; Barbosa-Coutinho LM; Oliveira MC
Braz J Med Biol Res; 2015 May; 48(5):415-9. PubMed ID: 25742638
[TBL] [Abstract][Full Text] [Related]
36. Expression of Ki-67 and p53 in meningiomas.
Pavelin S; Becic K; Forempoher G; Mrklic I; Pogorelic Z; Titlic M; Andelinovic S
Neoplasma; 2013; 60(5):480-5. PubMed ID: 23790165
[TBL] [Abstract][Full Text] [Related]
37. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
38. The significance of immunohistochemical expression of merlin, Ki-67, and p53 in meningiomas.
Pavelin S; Bečić K; Forempoher G; Tomić S; Capkun V; Drmić-Hofman I; Mrklić I; Lušić I; Pogorelić Z
Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):46-9. PubMed ID: 23455188
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting post-operative recurrence or growth of meningiomas, other than histological grade and extent of resection.
Quddusi A; Virani QU; Shamim MS
J Pak Med Assoc; 2019 Oct; 69(10):1570-1571. PubMed ID: 31622321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
